Keyphrases
18F-FLT
95%
Cancer Xenograft
50%
Nicotinamide Phosphoribosyltransferase (NAMPT)
47%
Positron Emission Tomography
47%
Antibacterial Activity
38%
18F-fluorodeoxyglucose (18F-FDG)
33%
Tumor
32%
18F-fluorothymidine
32%
Ovarian Cancer
31%
Anticancer Agents
29%
APO866
28%
Non-invasive Assessment
27%
Structure-activity Relationship
26%
Treatment Monitoring
26%
Experimental Chemotherapy
26%
Human Ovary
26%
Xenograft Tumor
26%
Peptide nucleic Acid
23%
E. Coli Pneumonia
23%
AcpP
23%
Treatment Response
23%
Human Ovarian Cancer
23%
Colistin-resistant
23%
Belinostat
23%
Hydrophobicity
23%
Drug Efficacy
23%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
23%
Bioisostere
23%
Peptide Conjugates
23%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
23%
Cell Selectivity
23%
Enzyme mutation
23%
Target Enzyme
23%
18F-FDG Positron Emission Tomography
23%
Orphan G Protein-coupled Receptor
23%
Cancer Treatment
23%
Peptide Hybrids
23%
Common Structure
23%
Hybrid Monomers
23%
Comparative Analysis
23%
GPR139
23%
Carboplatin
23%
Synthesis Effect
23%
Tetrahydroindole
23%
Paclitaxel
23%
Chemosensitivity
23%
Antisense
23%
Human Cancer
23%
Klebsiella Pneumoniae (K. pneumoniae)
23%
Sensitivity to Chemotherapy
23%
Medicine and Dentistry
Tumor Xenograft
100%
Fluorine-18
98%
Neoplasm
80%
positron emission tomographic scan
76%
Fluorodeoxyglucose F 18
74%
Ovarian Cancer
73%
Polyethylene Terephthalate
47%
Nicotinamide Phosphoribosyltransferase
47%
Daporinad
28%
Radioactive Tracer
28%
Treatment Response
26%
Cell Proliferation
25%
Non Invasive Procedure
23%
Chemotherapy
23%
Drug Efficacy
23%
Mouse Study
23%
Belinostat
23%
Patient Monitoring
23%
Carboplatin
23%
Paclitaxel
23%
Xenograft
23%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
69%
Neoplasm
49%
Anticancer Drug
23%
Colistimethate
23%
Carbene
23%
Fluorine 18
23%
Trypanosoma
23%
Breast Cancer
23%
Trypanosoma brucei
23%
Nicotinamide Phosphoribosyltransferase
23%
G Protein Coupled Receptor
23%
Peptide Nucleic Acid
23%
Chemotherapy
23%
Anticarcinogen
23%
Antiproliferative Activity
23%
Escherichia coli
23%
Histone Deacetylase
23%
Structure Activity Relationship
23%
Antibacterial Activity
15%
